Specialist treatment of CFS/ME: a cohort study among adult patients in England

Research abstract: 

Specialist treatment of chronic fatigue syndrome/ME: A cohort study among adult patients in England, by Simon M Collin, Esther Crawley in BMC Health Services Research Vol. 17, p 488 [published July 14, 2017]

Background:
NHS specialist chronic fatigue syndrome (CFS/ME) services in England treat approximately 8000 adult patients each year. Variation in therapy programmes and treatment outcomes across services has not been described.

Methods:
We described treatments provided by 11 CFS/ME specialist services and we measured changes in patient-reported fatigue (Chalder, Checklist Individual Strength), function (SF-36 physical subscale, Work & Social Adjustment Scale), anxiety and depression (Hospital Anxiety & Depression Scale), pain (visual analogue rating), sleep (Epworth, Jenkins), and
overall health (Clinical Global Impression) 1 year after the start of treatment, plus questions about impact of CFS/ME on employment, education/training and domestic tasks/unpaid work. A subset of these outcome measures was collected from former patients 2-5 years after assessment at 7 of the 11 specialist services.

Results:
Baseline data at clinical assessment were available for 952 patients, of whom 440 (46.2%) provided 1-year follow-up data. Treatment data were available for 435/440 (98.9%) of these patients, of whom 175 (40.2%) had been discharged at time of follow-up. Therapy programmes varied substantially in mode of delivery (individual or group) and number of
sessions.

Overall change in health 1 year after first attending specialist services was ‘very much’ or ‘much better’ for 27.5% (115/418) of patients, ‘a little better’ for 36.6% (153/418), ‘no change’ for 15.8% (66/418), ‘a little worse’ for 12.2% (51/418), and ‘worse’ or ‘very much worse’ for 7.9% (33/418).

Among former patients who provided 2- to 5-year follow-up (30.4% (385/1265)), these proportions were 30.4% (117/385), 27.5% (106/385), 11.4% (44/385), 13.5% (52/385), and 17.1% (66/385), respectively. 85.4% (327/383) of former patients responded ‘Yes’ to ‘Do you think that you are still suffering from CFS/ME?’ 8.9% (34/383) were ‘Uncertain’, and 5.7% (22/383) responded ‘No’.

Conclusions:
This multi-centre NHS study has shown that, although one third of patients reported substantial overall improvement in their health, CFS/ME is a long term condition that persists for the majority of adult patients even after receiving specialist treatment.

 

Posted in News | Tagged , , , | Comments Off on Specialist treatment of CFS/ME: a cohort study among adult patients in England

CFS, Bristol University, & controversial science

The Bristol Cable blog post, by Lorna Stephenson, 7 July 2017: Chronic fatigue syndrome, Bristol University, and controversial science,

Trials on certain treatments of chronic fatigue syndrome, or ME, have pitted patients against researchers, and scientists against scientists – amid furious clashes on the validity of landmark studies into the condition.

Can chronic fatigue syndrome (CFS), also known as ME, be treated with exercise and talking therapies? It’s a question that splits the scientific and patient advocacy communities, and has become the basis of an intense international dispute.

Scientists researching the treatments claim they’ve been subjected to harassment and abuse, including death threats. But critics say evidence for these behavioural treatments doesn’t stand up to scientific scrutiny, and that pursuing such lines of inquiry runs counter to mounting evidence that CFS is biological, not psychological.

Bristol University is at the centre of these controversies thanks to ongoing trials into exercise and talking therapies for teenagers with CFS, which is characterised by debilitating long-term fatigue that’s worse after exertion, plus symptoms such as chronic pain. The illness can last months or years and in severe cases leaves people bed-bound and even tube fed. CFS has also baffled scientists as to its causes and the biological markers that characterise it – and there’s no drug treatment for it, only medications that can help manage symptoms.

Bristol University’s current research, a trial known as FITNET-NHS, focuses on the efficacy of delivering cognitive behavioural therapy (CBT – a talking therapy) via the internet. Another trial, MAGENTA, recently looked at the outcomes of graded exercise therapy (GET), an approach via which patients follow a regime of gradually increased activity.

Despite the fact that the Bristol trials have got ethics approval, they’ve thrust the university into the spotlight of a worldwide controversy. Opponents, who include scientists and CFS advocacy groups as well as people with CFS, say GET and CBT treatments are harmful, have been tried before to no meaningful effect, and are only being pursued to protect the reputations of researchers and others in the medical science establishment who continue to study them despite them being debunked by a previous, flawed, trial.

Read more about PACE, FITNET, MAGENTA & Bristol University

 

 

Posted in News | Tagged , , , , , , | Comments Off on CFS, Bristol University, & controversial science

The case against Dr Speight has been dropped!

Congratulations to Dr Nigel Speight.  The General Medical Council have closed the case against him with no action taken!

Dr Nigel Speight

He says:

Naturally I am delighted.

Thanks you for all your generous support in the form of testimonials, it was like being able to read my own obituary without the disadvantage of actually having to die first!

 

Posted in News | Tagged , , | Comments Off on The case against Dr Speight has been dropped!

Differentiating MS from ME & CFS

Research abstract:

Differentiating Multiple Sclerosis from Myalgic Encephalomyelitis and Chronic Fatigue Syndrome, by LA Jason, D Ohanian, A Brown. M Sunnquist, S McManimen, L Klebek, P Fox and M Sorenson in Insights in Biomedicine Vol. 2 No. 2:11 2017

Multiple Sclerosis (MS), Myalgic Encephalomyelitis (ME), and Chronic Fatigue syndrome are debilitating chronic illnesses, with some overlapping symptoms. However, few studies have compared and contrasted symptom and disability profiles for these illnesses for the purpose of further differentiating them.

The current study was an online self-report survey that compared symptoms from a sample of individuals with MS (N = 120) with a sample of individuals with ME or CFS (N = 269). Respondents completed the self-report DePaul Symptom Questionnaire.

Those individuals with ME or CFS reported significantly more functional limitations and significantly more severe symptoms than those with MS. The implications of these findings are discussed.

Comment from ME Association: Review: People with ME/CFS are more functionally impaired than people with multiple sclerosis 

Posted in News | Tagged , , , , , , , , , , | Comments Off on Differentiating MS from ME & CFS

Using personal assistants works, research concludes… but it can go wrong

Disability news service blog post, by John Pring, 6 July: Using personal assistants works, research concludes… but it can go wrong

Enabling disabled people with support needs to employ personal assistants (PAs) – rather than relying on traditional care workers – can be empowering and liberating, but relationships with PAs “can sometimes go wrong”, according to new research.

The Personal Assistance Relationships study, led by the disabled academic Professor Tom Shakespeare (pictured), highlights the “complex” and “variable” nature of personal assistance relationships, and warns that they involve “a dynamic interplay of emotions, ethics and power”.

He told an event in London, held to launch the University of East Anglia research, that “personal assistance works” and that it provides disabled people with freedom and control.

But he added: “It is not straightforward, particularly for people who don’t come from the tradition of the disabled people’s movement.”

He told the launch event that personal assistance was “one of the revolutionary innovations of the disabled people’s movement”, alongside the concept of independent living.

Read more

see also:

UEA blog post: Personal assistance relationships are complex and need support,

Posted in News | Tagged , , , | Comments Off on Using personal assistants works, research concludes… but it can go wrong

Asserting privilege: PACE investigators’ request that their manuscript not be peer reviewed or receive replies

Quick thoughts blog post by James C Coyne, 11 July 2017: Asserting privilege: PACE investigators’ request that their manuscript not be peer reviewed or receive replies

After demanding parts of an article published in the Journal of Health Psychology be retracted, the PACE investigators requested their response be published without peer review and with no comments allowed.

This episode is part of a continuing saga of the PACE investigators attempts to exert extraordinary control over what is said about their work.

The predicament of the scientific community with respect to the PACE trial fits well with John Ioannidis  has termed “scientific inbreeding” where an interconnected group is able, temporarily at least, to dominate a scientific area and control and contain criticism of flaws consistently characterizing their work. We may well be witnessing a break in that control and the beginning of a decline effect, where independent critique and re-analysis of data make those flaws more inescapably obvious.

The emails that will be reproduced below came after the PACE investigators lobbied some members of editorial board and asked them to demand the article be retracted and to threaten resignation if it were not retracted.

Read more

 

Posted in News | Tagged , | 1 Comment

MEA research grant to Dr Keith Geraghty to examine two controversial ME/CFS treatments recommended by NICE

ME Association blog post, 13 July 2017: ME Association provide new research grant to Dr Keith Geraghty to examine two controversial ME/CFS treatments recommended by NICE

ME Association trustees have approved a new research grant that will critically examine the theoretical basis that underlies the use of Cognitive Behavioural Therapy (CBT) and Graded Exercise Therapy (GET) in ME/CFS.

The £25,000 grant – over two years – has been given to Dr Keith Geraghty at the University of Manchester and will challenge and review the theoretical basis and clinical application of CBT and GET in the NHS.

Dr Geraghty is an Honorary Research Fellow in Population Health, Health Sciences Research and Primary Care, where his work focuses on ME and CFS.

This new grant will fund an incremental study, in two main phases: phase 1 being a theoretical exploration of the CBT-model of ME/CFS and phase 2 being an empirical study of patients’ experiences of CBT and GET.

Its aim will be to better understand why clinical trials are reporting seemingly different effects than are demonstrated in patient surveys and clinical outcomes.

The hypotheses driving this research are that many of the benefits reported in clinical trials, even where modest, may actually come from factors unrelated to illness belief modification, such as therapy effects, stress management advice, lifestyle advice, the power of suggestion (being asked to think more positively).

The research will also examine whether patients are adequately informed of the rationale for CBT and GET therapies, or are entered into such treatments with strong promotion by physicians and therapists – thus increasing therapy and expectancy effects.

Also, that many false positive cases of ME/CFS may be diagnosed (primarily mental health complaints that mimic the symptoms of ME/CFS – such as fatigue and sleep disturbance), in the absence of careful screening and a proper understanding of the illness. This could mean we are not seeing a true record of outcomes for a ME/CFS population.

Read more

Posted in News | Tagged , , , , , , | Comments Off on MEA research grant to Dr Keith Geraghty to examine two controversial ME/CFS treatments recommended by NICE

Subtyping patients with ME & CFS by course of illness

Research Abstract:

Subtyping Patients with Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS) By Course of Illness, by Jamie Stoothoff, Kristen Gleason, Stephanie McManimen, Taylor Thorpe and Leonard A. Jason in Symbiosis: Journal of Biosensors, Biomarkers and Diagnostics [Published: June 26, 2017]

Past research has subtyped patients with Myalgic Encephalolyelitis (ME) and Chronic Fatigue Syndrome (CFS) according to factors related to illness onset, illness duration, and age. However, no classification system fully accounts for the wide range of symptom severity, functional disability, progression, and prognosis seen among patients.

This study examined whether illness trajectories among individuals with CFS were predictive of different levels of symptomology, functional disability, and energy expenditure.

Of the participants (N=541), the majority described their illness as Fluctuating (59.7%), with 15.9% Constantly Getting Worse, 14.1% Persisting, 8.5% Relapsing and Remitting, and 1.9% Constantly Getting Better. The illness courses were associated with significant differences in symptomology on select domains of the DSQ, functioning on select subscales of the SF-36, and on overall levels of energy expenditure.

The significant symptomatic and functional differences between groups suggest that subtyping patients with CFS according to illness course is a promising method for creating more homogeneous groups of patients.

Posted in News | Tagged , , , , , , | Comments Off on Subtyping patients with ME & CFS by course of illness

Medial prefrontal cortex deficits correlate with unrefreshing sleep in patients with CFS

Research abstract:

Medial prefrontal cortex deficits correlate with unrefreshing sleep in patients with chronic fatigue syndrome, by Zack Y. Shan, Richard Kwiatek, Richard Burnet, Peter Del Fante,  Donald R. Staines, Sonya M. Marshall-Gradisnik and Leighton R. Barnden in NMR in Biomedicine [Published online: 29 JUN 2017]

Unrefreshing sleep is a hallmark of chronic fatigue syndrome/myalgic encephalomyelitis (CFS).

This study examined brain structure variations associated with sleep quality in patients with CFS. 38 patients with CFS (34.8 ± 10.1 years old) and 14 normal controls (NCs) (34.7 ± 8.4 years old) were recruited.

All subjects completed the Hospital Anxiety and Depression Scale, Pittsburgh Sleep Quality Index (PSQI), and Chalder Fatigue Scale (CFQ) questionnaires. Brain MRI measures included global and regional grey and white matter volumes, magnetization transfer T1 weighted (MT-T1w) intensities, and T1 weighted (T1w) and T2 weighted spin echo signal intensities.

We performed voxel based group comparisons of these regional brain MRI measures and regressions of these measures with the PSQI and CFQ scales adjusted for age, anxiety and depression, and the appropriate global measure.

In CFS patients, negative correlations were observed in the medial prefrontal cortex (mPFC) between PSQI and MT-T1w intensities (family-wise error corrected cluster, PFWE < 0.05) and between PSQI and T1w intensities (PFWE < 0.05). In the same mPFC location, both MT and T1w intensities were lower in CFS patients compared with NCs (uncorrected voxel P < 0.001).

This study is the first to report that brain structural differences are associated with unrefreshing sleep in CFS. This result refutes the suggestion that unrefreshing sleep is a misperception in CFS patients and further investigation of this symptom is warranted.

Posted in News | Tagged , , , , , , , , , , , | Comments Off on Medial prefrontal cortex deficits correlate with unrefreshing sleep in patients with CFS

US health agency, CDC, drops CBT/GET on website

Article excerpts:

Virology blog post, by David Tuller, DrPH, 10 July 2017: Trial By Error: The CDC Drops CBT/GET

Just as The Lancet has published more “evidence” for graded exercise, the CDC has moved decisively in the opposite direction. In revamping the information on the part of its website geared toward the general public, the agency has “disappeared” all mention of CBT and GET as treatment or management strategies. Patients and advocates have long pushed for this step, as did Julie Rehmeyer and I in a New York Times opinion piece in March.

Although the revised text is dated as having been reviewed on May 30th, it apparently went live sometime during the first week of July. (The CDC has still not revised the pages designed for health care providers, although old information has been removed. The agency calls the illness ME/CFS.)For advocates, the CDC’s removal of the CBT/GET recommendations represents a major victory. “I think it’s huge,” said Mary Dimmock, an advocate who has long pressured the CDC to revise its website. Given the agency’s stature, she added, the decision could have widespread impact, not just in the U.S. but internationally as well. Many health care providers and institutions here and abroad look to the CDC for guidance in public health matters.

“So many patients have been made worse by the treatments,” said Dimmock, who became an advocate after her son became seriously ill several years ago. “While there is more to be done, removing these recommendations is a significant step forward in protecting ME patients from harm.”

In the revision, the CDC website has dropped the agency’s 1994 definition of the illness. The new definition, based on the one proposed in a 2015 report from the Institute of Medicine (now the Academy of Medicine), requires the presence of “post-exertional malaise.” In the 1994 definition, that was only one of eight optional symptoms. The immediate implication of the shift is that GET should likely be considered contraindicated, given the premium this intervention places on steadily boosting activity levels. The form of CBT prescribed in PACE could also be contraindicated, since the ultimate goal of that intervention is likewise to increase activity. (The CDC has not adopted the name proposed by the IOM report, “systemic exertion intolerance disease.”)

In addition to symptomatic relief, the revised CDC website suggests such management strategies as a balanced diet, nutritional supplements and complementary medicine. Here’s some of the new language on managing the illness that has displaced the previous sections on GET and CBT:

*Avoiding ‘push-and-crash’ cycles through carefully managing activity. “Push-and-crash” cycles are when someone with ME/CFS is having a good day and tries to push to do more than they would normally attempt (do too much, crash, rest, start to feel a little better, do too much once again). This can then lead to a “crash” (worsening of ME/CFS symptoms). Finding ways to make activities easier may be helpful, like sitting while doing the laundry or showering, taking frequent breaks, and dividing large tasks into smaller steps.

*Talking with a therapist to help find strategies to cope with the illness and its impact on daily life and relationships.

Of course, avoiding “push-and-crash” is what patients already do when they practice pacing. The “push-and-crash” language itself appears to be closely aligned with the arguments provided by the PACE investigators and their colleagues; many patients might describe their experiences differently. Nevertheless, removing the CBT/GET recommendations is a welcome step, if overdue. For years, patients and advocates pointed out the problems with PACE and related research, and also cited the evidence that too much exertion caused harm because of physiological abnormalities, not the deconditioning presumed by CBT and GET. But until now, the agency refused to make the necessary changes.

Read the full article

Posted in News | Tagged , , , , , , , , | Comments Off on US health agency, CDC, drops CBT/GET on website